News
December 30, 2020

New codes aid in tracking COVID-19 and fostering healthcare interoperability

LOINC releases new healthcare codes to track coronavirus

New codes aid in tracking COVID-19 and fostering healthcare interoperability

The international data standard LOINC® at Regenstrief Institute has released a new set of nearly 1,300 codes to identify health information, including terms related to the COVID-19 pandemic. These codes provide standardization to share and classify test results and other health information, which is especially crucial during a pandemic.

LOINC releases a formal update of its codes twice a year. Both of the updates in 2020 have prioritized terms and resources related to SARS-CoV-2-/COVID-19 testing, documentation and reporting. LOINC is working closely with the World Health Organization, the U.S. Centers for Disease Control and Prevention (CDC), the U.S. Food and Drug Administration, laboratories and in vitro diagnostic manufacturers to create these codes, which will be continuously updated.

15 codes in the new release were created for the WHO case reporting data elements, and 37 were created for the CDC Public Health Emergency Operations Center minimum data set.

LOINC, which stands for Logical Observation Identifiers Names and Codes, is a universal code that allows health records to be seamlessly exchanged between health systems and public health entities around the world. LOINC has users from nearly every country.

In addition to the 1,295 new terms added to this release, LOINC has released a Beta version of its redesigned search application. This will enable users to search for terms, as well as parts (the building block for terms), answer lists and groups.

LOINC is available free of charge.

Download version 2.69 here

About LOINC®

LOINC was created in 1994 at Regenstrief Institute to facilitate interoperability in healthcare. There was a growing trend to send clinical data electronically between healthcare entities, a practice that has now become ubiquitous. Today, it contains almost 95,000 terms for everything from a serum alpha 1 antitrypsin level to a zygomatic arch x-ray report. For each concept, LOINC contains many other rich details, such as synonyms, units of measure, and carefully crafted descriptions.

About Regenstrief Institute

Founded in 1969 in Indianapolis, the Regenstrief Institute is a local, national and global leader dedicated to a world where better information empowers people to end disease and realize true health. A key research partner to Indiana University, Regenstrief and its research scientists are responsible for a growing number of major healthcare innovations and studies. Examples range from the development of global health information technology standards that enable the use and interoperability of electronic health records to improving patient-physician communications, to creating models of care that inform practice and improve the lives of patients around the globe.

Sam Regenstrief, a nationally successful entrepreneur from Connersville, Indiana, founded the institute with the goal of making healthcare more efficient and accessible for everyone. His vision continues to guide the institute’s research mission.

 

Related News

Regenstrief to host semiannual LOINC® conference in Washington, D.C., Sept. 17-20

Regenstrief Institute will host its semiannual LOINC® conference September 17-20, 2024, in Washington, D.C. LOINC, a global healthcare terminology

Telehealth Mindfulness-Based Interventions for Chronic Pain: The LAMP Randomized Clinical Trial

Telehealth Mindfulness-Based Interventions for Chronic Pain: The LAMP Randomized Clinical Trial

Published in JAMA Internal Medicine. Here is a link to the article. Regenstrief Institute author: Marianne S. Matthias, PhD

Andrew Gonzalez, MD, JD, MPH

Ensuring use of AI to improve health meets its full potential reliably and safely

Regenstrief research scientist is co-editor of National Academy of Medicine draft Code of Conduct for AI use INDIANAPOLIS –

Kathleen Unroe, M.D.

$15.5 million NIH award funds development of national network to include nursing home residents in clinical trials

INDIANAPOLIS – A team led by research scientists from the Indiana University School of Medicine and Regenstrief Institute has